Both sides are claiming victory after a federal judge’s ruling Friday in Eli Lilly’s lawsuit against federal health agencies in defense of its policies on 340B pricing when covered entities use contract pharmacies.
U.S. Senior Judge’s Sarah Evans Barker ruled on Oct. 29 that the U.S. Health Resources and Services Administration’s (HRSA) May 17 letter telling Lilly its contract pharmacy actions “have resulted in overcharges and are in direct violation of the 340B statute” was arbitrary and capricious in violation of the Administrative Procedure Act (APA).
340B stakeholders are still digesting a federal district judge’s ruling Friday in drug manufacturer Eli Lilly’s lawsuit against federal health agencies in defense of its policies on 340B pricing when covered entities use contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
